Diagnosis and Treatment of Dry Eyes

Symptoms

Over 300 million people worldwide, including around 10 million in Germany, suffer from "dry eye syndrome."
Typical symptoms include:
- Redness and burning of the eyes
- A sensation of dryness or a foreign body
- Blurred vision
- Scratching, itching, or stinging

The underlying cause is an impaired wetting of the eye's surface, which may result from insufficient tear production, an imbalance in tear composition, or excessive evaporation of the tear film.

Modern lifestyles, characterized by prolonged screen use (computers, smartphones, tablets), air-conditioned environments, and side effects from medications or cosmetics, exacerbate these symptoms.

Most patients use eye drops several times daily for relief, unaware that this chronic condition can now be further diagnosed and, in some cases, treated non-invasively with light therapy.

Primary Cause of Dry Eyes: Meibomian Gland Dysfunction (MGD)

In 86% of cases, dry eyes are primarily caused by Meibomian Gland Dysfunction (MGD).
The Meibomian glands, located in the upper and lower eyelids, produce essential oils (lipids) that protect the eye's surface from diseases and prevent the rapid evaporation of the tear film
With every blink, fresh lipids are released and spread across the eye's surface, keeping it hydrated. However, blockages caused by deposits or mite infestations can lead to gland inflammation and, in severe cases, gland atrophy. This results in reduced lipid production and secretion, a condition known as MGD.

ME-Check for Diagnosing Meibomian Gland Dysfunction (MGD)

The ME-Check is a quick and simple diagnostic tool that uses infrared light to capture images of the eyelids, providing a clear view of the Meibomian glands.

With these images, the structure and condition of the glands can be evaluated. Using an international grading system and a brief questionnaire, your doctor can determine whether you have MGD and the severity of the condition.
The ME-Check also enables reliable monitoring and documentation of the disease’s progression.

Treatment of Meibomian Gland Dysfunction (MGD)

The Eye-Light system combines Optimal Power Energy Intense Pulsed Light (OPE-IPL) with Low-Level Light Therapy (LLLT) to gently and effectively treat both eyelids. 

This unique combination ensures rapid and effective results: Symptoms improve within hours after treatment and lipid production in the eye increases within a short time. Depending on the severity, 2–4 sessions may be required for optimal results.

1. OPE-IPL (Optimal Power Energy Intense Pulsed Light)

OPE-IPL uses polychromatic pulsed light to stimulate Meibomian gland function in the lower eyelid. Five small light pulses applied to the cheekbone area stimulate gland contraction and restore lipid flow. Treatment takes only a few seconds.

2. LLLT (Low-Level Light Therapy)

LLLT targets the Meibomian glands in the upper eyelid, which are longer and play a crucial role in protecting the eye's surface. Light emission at a specific wavelength generates heat in the skin, enhancing lipid flow. A wellness-like treatment delivered via a mask, lasting about 15 minutes.

LLLT has been successfully used for years in dentistry and dermatology for treating palate and skin conditions.

Cost of treatment

The cost per treatment (both eyes) is approx. € 250. We suggest 3 consecutive treatments at intervals of 3-4 weeks followed by a 6 months break.